GB201913123D0 - Compositions and methods for treatment of cholangiocarcinoma - Google Patents

Compositions and methods for treatment of cholangiocarcinoma

Info

Publication number
GB201913123D0
GB201913123D0 GBGB1913123.4A GB201913123A GB201913123D0 GB 201913123 D0 GB201913123 D0 GB 201913123D0 GB 201913123 A GB201913123 A GB 201913123A GB 201913123 D0 GB201913123 D0 GB 201913123D0
Authority
GB
United Kingdom
Prior art keywords
cholangiocarcinoma
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1913123.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seald As
Original Assignee
Seald As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seald As filed Critical Seald As
Priority to GBGB1913123.4A priority Critical patent/GB201913123D0/en
Publication of GB201913123D0 publication Critical patent/GB201913123D0/en
Priority to PCT/EP2020/075563 priority patent/WO2021048418A1/en
Ceased legal-status Critical Current

Links

GBGB1913123.4A 2019-09-11 2019-09-11 Compositions and methods for treatment of cholangiocarcinoma Ceased GB201913123D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1913123.4A GB201913123D0 (en) 2019-09-11 2019-09-11 Compositions and methods for treatment of cholangiocarcinoma
PCT/EP2020/075563 WO2021048418A1 (en) 2019-09-11 2020-09-11 Combination therapies comprising bortezomib for the treatment of cholangiocarcinoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1913123.4A GB201913123D0 (en) 2019-09-11 2019-09-11 Compositions and methods for treatment of cholangiocarcinoma

Publications (1)

Publication Number Publication Date
GB201913123D0 true GB201913123D0 (en) 2019-10-23

Family

ID=68241081

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1913123.4A Ceased GB201913123D0 (en) 2019-09-11 2019-09-11 Compositions and methods for treatment of cholangiocarcinoma

Country Status (2)

Country Link
GB (1) GB201913123D0 (en)
WO (1) WO2021048418A1 (en)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101481359A (en) 1999-04-15 2009-07-15 布里斯托尔-迈尔斯斯奎布公司 Cyclic protein tyrosine kinase inhibitors
PE20020354A1 (en) 2000-09-01 2002-06-12 Novartis Ag HYDROXAMATE COMPOUNDS AS HISTONE-DESACETILASE (HDA) INHIBITORS
PL1663978T3 (en) * 2003-07-23 2008-04-30 Bayer Healthcare Llc Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
US20070105867A1 (en) 2005-09-21 2007-05-10 Bristol-Myers Squibb Company Oral administration of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
BRPI0715844A2 (en) 2006-08-23 2013-11-26 Korea Res Inst Of Bioscience PHARMACEUTICAL COMPOSITION FOR TREATMENT OF COLANGIOCARCINOMA, METHOD OF INHIBITION OF GROWTH OR INVASION OF COLANGIOCARCINOMA AND METHOD OF TREATMENT OF COLANGIOCARCINOMA
EP2776021A1 (en) 2011-11-10 2014-09-17 Synta Pharmaceuticals Corp. Administration of a bis(thiohydrazide amide) compound for treating cancers
HU231013B1 (en) 2014-05-26 2019-11-28 Egis Gyógyszergyár Zrt. Dasatinib salts
WO2016166653A1 (en) 2015-04-13 2016-10-20 Leiutis Pharmaceuticals Pvt Ltd Stable liquid pharmaceutical compositions of bortezomib
CN108135900A (en) 2015-09-04 2018-06-08 亚狮康私人有限公司 Comprising Giovanni for Buddhist nun and the combination treatment of anticancer agent
GB201609193D0 (en) 2016-05-25 2016-07-06 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
WO2018153971A1 (en) * 2017-02-24 2018-08-30 Bayer Pharma Aktiengesellschaft Combination of atr kinase inhibitors
BR112019024007A2 (en) * 2017-05-16 2020-07-07 Biomed Valley Discoveries, Inc. compositions and methods for treating cancer with atypical braf mutations
US10933061B2 (en) * 2017-12-21 2021-03-02 Shepherd Therapeutics, Inc. Pyrvinium pamoate therapies and methods of use

Also Published As

Publication number Publication date
WO2021048418A1 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
EP3833340A4 (en) Compositions and methods for treatment of presbyopia
IL285886A (en) Compositions and methods for treating laminopathies
SG11202103033WA (en) Compositions and methods for the treatment of presbyopia
IL280413A (en) Bismuth-thiol compositions and methods for treating wounds
EP3843524A4 (en) Seed treatment composition and method of using
IL308221A (en) Compositions and methods for the treatment of depression
EP4003246A4 (en) Compositions and methods for treatment of presbyopia
IL289251A (en) Methods and compositions for treatment of pancreatic cancer
GB201913122D0 (en) Compositions and methods for treatment of cholangiocarcinoma
IL278978A (en) Compositions and methods for treatment of psoriasis
IL273850A (en) Compositions and methods for treatment of fibrosis
EP3810647A4 (en) Methods and compositions for treatment of hemophilia
GB201913124D0 (en) Compositions and methods for treatment of cholangiocarcinoma
GB201913121D0 (en) Compositions and methods for treatment of cholangiocarcinoma
IL288353A (en) Methods of treating cholangiocarcinoma
EP3616705A4 (en) Composition for improving prevention and treatment of fatty liver containingamomum vilosum
IL288415A (en) Compositions and methods for treatment of hemochromatosis
IL289236A (en) Compositions and methods for treatment of fungal infections
IL285796A (en) Methods and compositions for treating
DK3359209T3 (en) Compositions and methods for treatment of bone defects
GB201810923D0 (en) Compositions and method of treatment
GB201913123D0 (en) Compositions and methods for treatment of cholangiocarcinoma
SG11202107355RA (en) Improved method and compositions for surface treatment
EP3784261A4 (en) Compositions and methods for prophylaxis or treatment of pain
GB201901219D0 (en) Compositions and methods of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)